Showing results (731-740 of 9,402) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|October 8, 1999
Vanadate stimulation of adenylyl cyclase: an index of tyrosine kinase vascular effectsC M Tan, C G McDonald, J Chorazyczewski, et al.Clinical Pharmacology and Therapeutics|October 8, 1999
Psychotropic drugs in acute intermittent porphyriaS Holroyd, R L SewardClinical Pharmacology and Therapeutics|August 3, 1999
In vitro metabolic interaction studies: experience of the Food and Drug AdministrationR Yuan, T Parmelee, J D Balian, et al.Clinical Pharmacology and Therapeutics|August 3, 1999
Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolamV J Palkama, J Ahonen, P J Neuvonen, et al.Clinical Pharmacology and Therapeutics|August 3, 1999
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjectsJ Rossat, M Maillard, J Nussberger, et al.Clinical Pharmacology and Therapeutics|August 3, 1999
Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjectsJ T Barbey, M E Sale, R L Woosley, et al.Clinical Pharmacology and Therapeutics|March 10, 2001
Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycinT Furuta, N Shirai, M Takashima, et al.Clinical Pharmacology and Therapeutics|October 1, 1975
Relative potency of prorenoate and spironolactone in normal manL Ramsay, I Harrison, J Shelton, et al.Clinical Pharmacology and Therapeutics|October 1, 1975
Temporal variations in acetaminophen and phenacetin half-life in manC A Shively, E S VesellClinical Pharmacology and Therapeutics|October 1, 1975
Effects of ticlopidine, a new platelet aggregation inhibitor in manJ J Thebault, C E Blatrix, J F Blanchard, et al.Pageof 941